1.
Kabir A. BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. Bangla J Med [Internet]. 2024 Jun. 6 [cited 2024 Dec. 25];35(20):165. Available from: https://banglajol.info/index.php/BJMED/article/view/73432